Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices $1.3B Senior Notes Offering

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced its $1.3 billion offering of senior notes, the firm announced after the close of the market yesterday.

It is offering $500 million of 1.85 percent senior notes due 2018, and $800 million of 3.15 percent notes due 2023. The firm expects to close the offering on Aug. 22.

As reported yesterday, Thermo Fisher intends to use the proceeds from the notes offering to fund its $925 million acquisition of One Lambda, a transplant diagnostics firm.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.